Trials / Unknown
UnknownNCT04367428
Pre- and Postoperative Probiotics Administration in Patients Undergoing Sleeve Gastrectomy
Effects of Pre- and Postoperative Probiotics Administration on Postoperative Weight Loss in Patients Undergoing Sleeve Gastrectomy
- Status
- Unknown
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 60 (estimated)
- Sponsor
- Hospital General Universitario Elche · Academic / Other
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
Patients will be randomized into 2 groups: * G1: Patients undergoing sleeve gastrectomy as bariatric procedure and receiving pre- and postoperative probiotics * G2: Patients undergoing sleeve gastrectomy as bariatric procedure and not receiving pre- or postoperative probiotics Weight loss will be assessed 1 year after surgery
Detailed description
Patients will be randomized into 2 groups: * G1: Patients undergoing sleeve gastrectomy as bariatric procedure and receiving pre- and postoperative probiotics * G2: Patients undergoing sleeve gastrectomy as bariatric procedure and not receiving pre- or postoperative probiotics Preoperative probiotics scheme include: * saccharomyces boulardii ntc 5375 + enterococcus faecium UBEF-41 + lactobacillus acidophilus LA 14 during 15 days (between 6th and 4th weeks before surgery) * Bifidobacterium lactis BL 04 + Bifidobacterium breve BB 03 + Bifidobacterium bifidum BB 06 + Bifidobacterium longum BL 05 during 15 days (between 4th and 2nd weeks before surgery) * lactobacillus rhamnosus LR 32 + lactobacillus rhamnosus HN001 + lactobacillus acidophillus LA 14 during 15 days (between 2nd week and the day before surgery) Postoperative probiotics scheme include: * saccharomyces boulardii ntc 5375 + enterococcus faecium UBEF-41 + lactobacillus acidophilus LA 14 during 15 days (between 1st and 3rd weeks after surgery) * Lactobacillus rhamnosus LR 32 + Bifidobacterium lactis BL 04 + Bifidobacterium longum BL 05 + lactobacillus salivarius LS 33 + lactobacillus acidophilus LA 14 + bifidobacterium bifidum BGN 4 during 4 months (between 4th and 20th weeks after surgery. Both groups will receive the same nutritional recommendations. 1 year after surgery, weight los will be assessed as primary outcome. Secondary outcomes will include daibetes mellitus remission and dyslipidemia remission. Weight loss will be assessed 1 year after surgery
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BIOLOGICAL | Administration of probiotics | Patients will receive the previously mentioned combination of probiotics before and after surgery |
Timeline
- Start date
- 2020-05-02
- Primary completion
- 2021-07-31
- Completion
- 2021-07-31
- First posted
- 2020-04-29
- Last updated
- 2020-04-29
Source: ClinicalTrials.gov record NCT04367428. Inclusion in this directory is not an endorsement.